Filing Details
- Accession Number:
- 0001209191-15-025188
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-11 16:35:24
- Reporting Period:
- 2015-03-09
- Filing Date:
- 2015-03-11
- Accepted Time:
- 2015-03-11 16:35:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1604464 | Atara Biotherapeutics Inc. | ATRA | Biological Products, (No Disgnostic Substances) (2836) | 460920988 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1216955 | S Joel Marcus | C/O Alexandria Real Estate Equities, Inc 385 East Colorado Boulevard, Suite 299 Pasadena CA 91101 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-03-09 | 2,500 | $29.32 | 2,500 | No | 4 | P | Indirect | Held by the Joel S. Marcus and Barbara A. Marcus Family Trust |
Common Stock | Acquisiton | 2015-03-10 | 1,500 | $29.99 | 4,000 | No | 4 | P | Indirect | Held by the Joel S. Marcus and Barbara A. Marcus Family Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Held by the Joel S. Marcus and Barbara A. Marcus Family Trust |
No | 4 | P | Indirect | Held by the Joel S. Marcus and Barbara A. Marcus Family Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 908,355 | Indirect | See Footnote |
Footnotes
- The shares were purchased at prices ranging from $28.95 to $29.35. The reporting person will provide upon request to the SEC, the issuer or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- The shares were purchased at prices ranging from $29.97 to $30.00. The reporting person will provide upon request to the SEC, the issuer or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.